应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARWR Arrowhead Research Corporation
已收盘 07-21 16:00:00 EDT
14.71
-2.05
-12.23%
盘后
15.00
+0.29
+1.97%
19:56 EDT
最高
17.00
最低
14.33
成交量
674.65万
今开
16.96
昨收
16.76
日振幅
15.96%
总市值
20.31亿
流通市值
17.78亿
总股本
1.38亿
成交额
1.01亿
换手率
5.58%
流通股本
1.21亿
市净率
2.97
ROE
-26.22%
每股收益
-1.14
52周最高
29.86
52周最低
9.57
市盈率
-12.94
股息
0.00
股息收益率
0.00
ROA
-5.86%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.00%报17.68美元
市场透视 · 07-15
Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.00%报17.68美元
Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.11%
市场透视 · 07-08
Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.11%
Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.07%报16.91美元
市场透视 · 07-02
Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.07%报16.91美元
Arrowhead Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%
市场透视 · 05-29
Arrowhead Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%
Arrowhead Pharmaceuticals, Inc.2025财年第一财季实现净利润3.70亿美元,同比增加396.00%
市场透视 · 05-18
Arrowhead Pharmaceuticals, Inc.2025财年第一财季实现净利润3.70亿美元,同比增加396.00%
异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘中大涨12.74%
异动解读 · 05-16
异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘中大涨12.74%
花旗:维持Arrowhead Pharma评级,由中性调整至中性评级, 目标价由21.00美元调整至17.00美元。
金融界 · 05-13
花旗:维持Arrowhead Pharma评级,由中性调整至中性评级, 目标价由21.00美元调整至17.00美元。
异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘中大涨12.74%
异动解读 · 05-13
异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘中大涨12.74%
异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘前大涨10.02%
异动解读 · 05-13
异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘前大涨10.02%
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.01%
市场透视 · 05-06
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.01%
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报14.75美元
市场透视 · 05-02
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报14.75美元
Arrowhead Pharmaceuticals, Inc.盘中异动 急速上涨5.01%
市场透视 · 04-30
Arrowhead Pharmaceuticals, Inc.盘中异动 急速上涨5.01%
Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.52%
市场透视 · 04-21
Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.52%
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.36%
市场透视 · 04-16
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.36%
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.13%报11.68美元
市场透视 · 04-11
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.13%报11.68美元
Arrowhead Pharmaceuticals, Inc.盘中异动 急速跳水5.14%
市场透视 · 03-04
Arrowhead Pharmaceuticals, Inc.盘中异动 急速跳水5.14%
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.08%
市场透视 · 02-24
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.08%
“减脂不减肌”:药企竞逐下一代减肥药新突破
老虎资讯综合 · 02-20
“减脂不减肌”:药企竞逐下一代减肥药新突破
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.37%报18.85美元
市场透视 · 02-11
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.37%报18.85美元
Arrowhead Pharma 2025财年第一季度GAAP每股收益$(1.39),不及预期$(0.63),销售收入$2.50M,不及预期$65.47M
财报速递 · 02-10
Arrowhead Pharma 2025财年第一季度GAAP每股收益$(1.39),不及预期$(0.63),销售收入$2.50M,不及预期$65.47M
加载更多
公司概况
公司名称:
Arrowhead Research Corporation
所属市场:
NASDAQ
上市日期:
1993-06-16
主营业务:
Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立,后在特拉华州重新注册成立。该公司开发药物,通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式,该公司的疗法触发RNA干扰机制,以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。
发行价格:
--
{"stockData":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Research Corporation","latestPrice":14.71,"timestamp":1753128000000,"preClose":16.76,"halted":0,"volume":6746546,"hourTrading":{"tag":"盘后","latestPrice":15,"preClose":14.71,"latestTime":"19:56 EDT","volume":4959,"amount":73240.58,"timestamp":1753142189662},"delay":0,"floatShares":120895799,"shares":138100435,"eps":-1.136657,"marketStatus":"已收盘","change":-2.05,"latestTime":"07-21 16:00:00 EDT","open":16.96,"high":17,"low":14.325,"amount":100764650.207494,"amplitude":0.159606,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.136657,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":740203200000,"exchange":"NASDAQ","adjPreClose":16.76,"preHourTrading":{"tag":"盘前","latestPrice":16.99,"preClose":16.76,"latestTime":"09:22 EDT","volume":4187,"amount":71322.02792,"timestamp":1753104175924},"postHourTrading":{"tag":"盘后","latestPrice":15,"preClose":14.71,"latestTime":"19:56 EDT","volume":4959,"amount":73240.58,"timestamp":1753142189662},"volumeRatio":4.005519,"optionData":{"bulkOrders":[{"symbol":"ARWR","call":true,"expireDate":1758254400000,"strike":"17.0","timestamp":1753106659004,"price":1.5,"volume":1579,"amount":236850,"type":"-"},{"symbol":"ARWR","call":true,"expireDate":1758254400000,"strike":"17.0","timestamp":1753106690984,"price":1.55,"volume":1575,"amount":244125,"type":"+"}]},"impliedVol":0.9997,"impliedVolPercentile":0.968},"requestUrl":"/m/hq/s/ARWR","defaultTab":"news","newsList":[{"id":"2551194869","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.00%报17.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194869?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:55","pubTimestamp":1752605757,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日02时55分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价快速下跌5.00%。截至发稿,该股报17.68美元/股,成交量63.4955万股,换手率0.46%,振幅6.50%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.24%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3520.75%、2114.80%、1562.50%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.,振幅分别为444.11%、116.77%、75.50%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716025557a44cef2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716025557a44cef2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","ARWR","BK4139"],"gpt_icon":0},{"id":"2550823527","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550823527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550823527?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:49","pubTimestamp":1751996955,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时49分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.11%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.08%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Zyversa Therapeutics, Inc.、Seastar Medical Holding Corporation涨幅较大,Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃,换手率分别为4001.70%、620.69%、341.39%,振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为146.75%、73.81%、70.97%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709014916a43e82f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709014916a43e82f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2548814114","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.07%报16.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548814114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548814114?lang=zh_cn&edition=full","pubTime":"2025-07-03 01:54","pubTimestamp":1751478892,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日01时54分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.07%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。其相关个股中,Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃,换手率分别为2515.91%、2036.48%、1250.78%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.,振幅分别为1145.92%、393.59%、152.07%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301545297978f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301545297978f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2539326194","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539326194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539326194?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:53","pubTimestamp":1748530430,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时53分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.01%。截至发稿,该股报16.34美元/股,成交量30.5751万股,换手率0.22%,振幅5.08%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.73%。其相关个股中,Alzamend Neuro, Inc.、Oric Pharmaceuticals, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大,Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为7792.42%、530.23%、381.34%,振幅较大的相关个股有Alzamend Neuro, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为61.45%、52.38%、50.55%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225350a6f20566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225350a6f20566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4585","BK4588","ARWR","BK4539","BK4139"],"gpt_icon":0},{"id":"2536594142","title":"Arrowhead Pharmaceuticals, Inc.2025财年第一财季实现净利润3.70亿美元,同比增加396.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594142","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594142?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584052,"startTime":"0","endTime":"0","summary":"5月19日,Arrowhead Pharmaceuticals, Inc.公布财报,公告显示公司2025财年第一财季净利润为3.70亿美元,同比增加396.00%;其中营业收入为5.43亿美元,每股基本收益为2.78美元。从资产负债表来看,Arrowhead Pharmaceuticals, Inc.总负债8.89亿美元,其中短期债务71.78百万美元,资产负债比为1.77,流动比率为5.14。机构评级:截至2025年5月19日,当前有13家机构对Arrowhead Pharmaceuticals, Inc.目标价做出预测,其中目标均价为42.31美元,其中最低目标价为17.00美元,最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000257a6e3a78a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000257a6e3a78a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"1166215888","title":"异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘中大涨12.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166215888","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166215888?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:53","pubTimestamp":1747378399,"startTime":"0","endTime":"0","summary":"生物技术公司Arrowhead Pharmaceuticals周二盘中股价大涨12.74%,主要受到该公司最新季度财报超出市场预期的推动。根据公司公布的财报,截至3月31日的季度中,Arrowhead Pharmaceuticals实现调整后每股收益2.75美元,远超分析师平均预期的每股亏损0.20美元。这一出色的业绩表现令投资者感到惊喜,推动公司股价在盘中交易中显著上涨。值得注意的是,尽管公司业绩表现亮眼,加拿大皇家银行仍将Arrowhead Pharmaceuticals的目标价从42美元下调至40美元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"2535087937","title":"花旗:维持Arrowhead Pharma评级,由中性调整至中性评级, 目标价由21.00美元调整至17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087937","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535087937?lang=zh_cn&edition=full","pubTime":"2025-05-14 03:29","pubTimestamp":1747164594,"startTime":"0","endTime":"0","summary":"花旗:维持Arrowhead Pharma(ARWR.US)评级,由中性调整至中性评级, 目标价由21.00美元调整至17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051403341194f5e29c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051403341194f5e29c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"1185804887","title":"异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘中大涨12.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185804887","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185804887?lang=zh_cn&edition=full","pubTime":"2025-05-13 21:34","pubTimestamp":1747143265,"startTime":"0","endTime":"0","summary":"生物技术公司Arrowhead Pharmaceuticals周二盘中股价大涨12.74%,主要受到该公司最新季度财报超出市场预期的推动。根据公司公布的财报,截至3月31日的季度中,Arrowhead Pharmaceuticals实现调整后每股收益2.75美元,远超分析师平均预期的每股亏损0.20美元。这一出色的业绩表现令投资者感到惊喜,推动公司股价在盘中交易中显著上涨。值得注意的是,尽管公司业绩表现亮眼,加拿大皇家银行仍将Arrowhead Pharmaceuticals的目标价从42美元下调至40美元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"1192967395","title":"异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘前大涨10.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192967395","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192967395?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:14","pubTimestamp":1747124087,"startTime":"0","endTime":"0","summary":"生物技术公司Arrowhead Pharmaceuticals周二盘前股价大涨10.02%,主要受到该公司最新季度财报超出市场预期的推动。根据公司公布的财报,截至3月31日的季度中,Arrowhead Pharmaceuticals实现调整后每股收益2.75美元,远超分析师平均预期的每股亏损0.20美元。这一出色的业绩表现令投资者感到惊喜,推动公司股价在盘前交易中显著上涨。值得注意的是,尽管公司业绩表现亮眼,加拿大皇家银行仍将Arrowhead Pharmaceuticals的目标价从42美元下调至40美元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"异动解读 | 业绩超预期,Arrowhead Pharmaceuticals盘前大涨10.02%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"2533542416","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533542416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533542416?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:48","pubTimestamp":1746546527,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时48分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.01%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为4.83%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为7652.38%、1176.74%、461.19%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ,振幅分别为158.45%、42.31%、39.52%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062348479750dacd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062348479750dacd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ARWR","BK4588","KTTA"],"gpt_icon":0},{"id":"2532262823","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报14.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532262823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532262823?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:01","pubTimestamp":1746198075,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时01分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.03%。截至发稿,该股报14.75美元/股,成交量25.8123万股,换手率0.19%,振幅3.85%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.27%。其相关个股中,Polyrizon Ltd.、Impact Biomedical, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃,换手率分别为745.82%、617.42%、517.39%,振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为267.88%、112.75%、71.36%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230115a6d12c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230115a6d12c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4585","ARWR","BK4588","IBO"],"gpt_icon":0},{"id":"2532643770","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532643770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532643770?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:20","pubTimestamp":1746037216,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时20分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.01%。截至发稿,该股报14.15美元/股,成交量77.9398万股,换手率0.57%,振幅8.31%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.35%。其相关个股中,Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc.涨幅较大,Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃,换手率分别为164.26%、41.21%、37.10%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Osr Holdings Inc C/Wts 09/02/2028 ,振幅分别为64.00%、37.52%、34.25%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022016aa2c8013&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022016aa2c8013&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","ARWR","BK4139"],"gpt_icon":0},{"id":"2529148383","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529148383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529148383?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:24","pubTimestamp":1745245463,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时24分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.52%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.涨幅较大,Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为1013.34%、710.97%、530.53%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为106.34%、58.81%、43.24%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222424a4612c1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222424a4612c1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2527249814","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527249814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527249814?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:46","pubTimestamp":1744811201,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时46分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.36%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.97%。其相关个股中,Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.涨幅较大,Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为418.75%、149.47%、62.74%,振幅较大的相关个股有天演药业、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为20.62%、20.00%、19.94%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214642a6bca6db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214642a6bca6db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2526132836","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.13%报11.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526132836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526132836?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:58","pubTimestamp":1744390685,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时58分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.13%。截至发稿,该股报11.68美元/股,成交量74.5574万股,换手率0.54%,振幅8.10%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.82%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为2099.37%、1519.02%、386.29%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.,振幅分别为193.75%、156.27%、77.44%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412005805a6b7fe2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412005805a6b7fe2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","ARWR","BK4139","BK4585"],"gpt_icon":0},{"id":"2516727646","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516727646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516727646?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:37","pubTimestamp":1741099028,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时37分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.14%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1088.65%、1075.19%、426.90%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Adma Biologics Inc,振幅分别为23.30%、22.25%、12.57%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223709abe7f1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223709abe7f1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","ARWR","BK4585","BK4139"],"gpt_icon":0},{"id":"2513472704","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513472704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513472704?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409374,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.08%。截至发稿,该股报18.89美元/股,成交量10.6991万股,换手率0.08%,振幅4.92%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Avalo Therapeutics, Inc.涨幅较大,Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为156.52%、69.90%、25.47%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ,振幅分别为137.23%、55.69%、41.14%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230254a2521c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230254a2521c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","ARWR"],"gpt_icon":0},{"id":"1166835000","title":"“减脂不减肌”:药企竞逐下一代减肥药新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1166835000","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166835000?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:58","pubTimestamp":1740045485,"startTime":"0","endTime":"0","summary":"罗氏计划今年启动中期试验,将其与自研GLP-1减肥候选药CT-388联用。BiohavenBiohaven在一项早期肥胖试验中评估其靶向肌肉生长抑制素的药物taldefgrobep alfa。该药虽未改善脊髓性肌萎缩症患者的运动功能,但减少了总体脂肪量,并在去脂体重和骨密度方面优于安慰剂。公司将在男性肥胖患者的早期研究中评估安全性,数据预计2025年一季度公布。","market":"us","thumbnail":"https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“减脂不减肌”:药企竞逐下一代减肥药新突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU","SRRK","REGN","ELAB","AZN","KROS","LLY","ARWR","RHHBY"],"gpt_icon":1},{"id":"2510638778","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.37%报18.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510638778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510638778?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:33","pubTimestamp":1739284385,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时33分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.37%。截至发稿,该股报18.85美元/股,成交量9.4729万股,换手率0.08%,振幅7.88%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.95%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃,换手率分别为1975.34%、526.25%、177.17%,振幅较大的相关个股有In8Bio, Inc.、Akari Therapeutics Plc、Lipella Pharmaceuticals Inc.,振幅分别为25.06%、16.07%、16.06%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223305a241fb70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223305a241fb70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ARWR","BK4588"],"gpt_icon":0},{"id":"1131801335","title":"Arrowhead Pharma 2025财年第一季度GAAP每股收益$(1.39),不及预期$(0.63),销售收入$2.50M,不及预期$65.47M","url":"https://stock-news.laohu8.com/highlight/detail?id=1131801335","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131801335?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:16","pubTimestamp":1739222217,"startTime":"0","endTime":"0","summary":"Arrowhead Pharma公布季度每股亏损$,比分析师一致预期的$低120.63%。与去年同期$3.55百万的销售收入相比下降29.60%。以上内容来自Benzinga Earnings专栏,原文如下:Arrowhead Pharma reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 120.63 percent. This is a 12.1 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $2.50 million which missed the analyst consensus estimate of $65.47 million by 96.18 percent. This is a 29.60 percent decrease over sale","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Arrowhead Pharma 2025财年第一季度GAAP每股收益$(1.39),不及预期$(0.63),销售收入$2.50M,不及预期$65.47M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arrowheadpharma.com","stockEarnings":[{"period":"1week","weight":-0.0847},{"period":"1month","weight":0.073},{"period":"3month","weight":0.4911},{"period":"6month","weight":-0.1431},{"period":"1year","weight":-0.3936},{"period":"ytd","weight":-0.1085}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立,后在特拉华州重新注册成立。该公司开发药物,通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式,该公司的疗法触发RNA干扰机制,以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.47619,"avgChangeRate":0.008191},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.00488},{"month":3,"riseRate":0.52381,"avgChangeRate":0.053201},{"month":4,"riseRate":0.47619,"avgChangeRate":0.025874},{"month":5,"riseRate":0.380952,"avgChangeRate":0.008317},{"month":6,"riseRate":0.571429,"avgChangeRate":0.023453},{"month":7,"riseRate":0.619048,"avgChangeRate":0.057316},{"month":8,"riseRate":0.4,"avgChangeRate":-0.005854},{"month":9,"riseRate":0.5,"avgChangeRate":0.039058},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.040731},{"month":11,"riseRate":0.52381,"avgChangeRate":0.052244},{"month":12,"riseRate":0.428571,"avgChangeRate":0.045143}],"exchange":"NASDAQ","name":"Arrowhead Research Corporation","nameEN":"Arrowhead Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arrowhead Research Corporation,ARWR,Arrowhead Research Corporation股票,Arrowhead Research Corporation股票老虎,Arrowhead Research Corporation股票老虎国际,Arrowhead Research Corporation行情,Arrowhead Research Corporation股票行情,Arrowhead Research Corporation股价,Arrowhead Research Corporation股市,Arrowhead Research Corporation股票价格,Arrowhead Research Corporation股票交易,Arrowhead Research Corporation股票购买,Arrowhead Research Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}